ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 218 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,433,363 | -15.0% | 136,641 | +6.5% | 0.00% | 0.0% |
Q3 2023 | $1,685,838 | -17.1% | 128,298 | -17.6% | 0.00% | 0.0% |
Q2 2023 | $2,032,537 | 0.0% | 155,750 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2,032,537 | -19.4% | 155,750 | +8.9% | 0.00% | 0.0% |
Q4 2022 | $2,521,850 | -99.9% | 142,962 | -6.0% | 0.00% | 0.0% |
Q3 2022 | $2,316,878,000 | -11.8% | 152,126 | -14.1% | 0.00% | 0.0% |
Q2 2022 | $2,627,045,000 | -27.5% | 177,144 | +10.1% | 0.00% | -50.0% |
Q1 2022 | $3,624,120,000 | +7.2% | 160,929 | -12.2% | 0.00% | +100.0% |
Q4 2021 | $3,380,465,000 | +16.6% | 183,223 | -15.5% | 0.00% | 0.0% |
Q3 2021 | $2,898,297,000 | -28.8% | 216,776 | -1.4% | 0.00% | -50.0% |
Q2 2021 | $4,067,960,000 | +42.4% | 219,771 | +15.5% | 0.00% | +100.0% |
Q1 2021 | $2,857,263,000 | -5.5% | 190,294 | -9.1% | 0.00% | 0.0% |
Q4 2020 | $3,023,505,000 | +79.8% | 209,384 | +1.3% | 0.00% | 0.0% |
Q3 2020 | $1,681,871,000 | +26.2% | 206,618 | +5.0% | 0.00% | 0.0% |
Q2 2020 | $1,332,409,000 | -17.0% | 196,811 | -13.7% | 0.00% | 0.0% |
Q1 2020 | $1,606,197,000 | -13.0% | 228,153 | +21.4% | 0.00% | 0.0% |
Q4 2019 | $1,845,181,000 | -7.4% | 187,996 | +3.6% | 0.00% | 0.0% |
Q3 2019 | $1,993,397,000 | +0.3% | 181,548 | +6.2% | 0.00% | 0.0% |
Q2 2019 | $1,988,404,000 | +29.1% | 170,972 | +5.9% | 0.00% | 0.0% |
Q1 2019 | $1,540,034,000 | +24.1% | 161,429 | +25.4% | 0.00% | 0.0% |
Q4 2018 | $1,240,851,000 | -26.9% | 128,719 | +8.0% | 0.00% | 0.0% |
Q3 2018 | $1,697,688,000 | +18.8% | 119,136 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,429,632,000 | -8.6% | 119,136 | -5.9% | 0.00% | 0.0% |
Q1 2018 | $1,563,954,000 | -13.7% | 126,636 | +1.7% | 0.00% | -50.0% |
Q4 2017 | $1,812,232,000 | +5.4% | 124,552 | +3.1% | 0.00% | 0.0% |
Q3 2017 | $1,719,012,000 | +22.2% | 120,802 | +9.5% | 0.00% | +100.0% |
Q2 2017 | $1,407,184,000 | -14.0% | 110,281 | -14.6% | 0.00% | -50.0% |
Q1 2017 | $1,637,064,000 | +163116.7% | 129,106 | +31.6% | 0.00% | +100.0% |
Q4 2016 | $1,003,000 | -48.3% | 98,140 | -33.3% | 0.00% | -50.0% |
Q3 2016 | $1,939,000 | +5.5% | 147,240 | +1.7% | 0.00% | 0.0% |
Q2 2016 | $1,838,000 | -3.9% | 144,761 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,912,000 | -30.0% | 144,761 | -18.5% | 0.00% | -33.3% |
Q4 2015 | $2,730,000 | +33.0% | 177,531 | +7.2% | 0.00% | +50.0% |
Q3 2015 | $2,053,000 | +10.2% | 165,575 | +21.6% | 0.00% | 0.0% |
Q2 2015 | $1,863,000 | +36.5% | 136,162 | +19.3% | 0.00% | +100.0% |
Q1 2015 | $1,365,000 | +15.0% | 114,162 | +22.8% | 0.00% | 0.0% |
Q4 2014 | $1,187,000 | -1.9% | 92,946 | +3.0% | 0.00% | 0.0% |
Q3 2014 | $1,210,000 | -16.5% | 90,246 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,449,000 | -9.9% | 90,246 | +1.1% | 0.00% | -50.0% |
Q1 2014 | $1,609,000 | +41.5% | 89,246 | +21.3% | 0.00% | +100.0% |
Q4 2013 | $1,137,000 | -4.1% | 73,546 | -7.8% | 0.00% | 0.0% |
Q3 2013 | $1,186,000 | +12.3% | 79,746 | -2.2% | 0.00% | 0.0% |
Q2 2013 | $1,056,000 | – | 81,546 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |